Target intelligence / Profile preview

Upstream master long non-coding RNA of the inflammatory chemokine locus (UMLILO)

Target
UMLILO
Molecular classification
Long non-coding RNA (lncRNA), Chromatin regulator, Gene-priming mediator, RNA gene
01

Overview

Upstream master long non-coding RNA of the inflammatory chemokine locus (UMLILO) is a long non-coding RNA that functions as a genomic organizer and priming mediator for the promoters of inflammatory CXCL chemokine genes located within the same topologically associating domain (TAD). UMLILO recruits the WDR5–MLL1 histone modification complex to chemokine gene promoters, resulting in H3K4me3 deposition, which establishes a primed chromatin state necessary for rapid and robust transcriptional activation during inflammation, as part of trained immunity. Unlike other immune gene-priming lncRNAs (IPLs), UMLILO is not conserved in murine genomes but is partially found in pigs, highlighting evolutionary and functional divergence. Loss of UMLILO impairs inflammatory chemokine gene expression; this can be functionally rescued by introducing other WDR5-binding lncRNAs under the UMLILO promoter. UMLILO represents an emerging therapeutic target in immune modulation but poses challenges due to its broad regulatory roles and limited cross-species conservation.

Other names
UMLILOupstream master lncRNA of the inflammatory chemokine locusimmune gene-priming lncRNA (IPL)
02

Mechanism of action

Drug targeting would likely involve inhibition or modulation of lncRNA expression/function, or disruption of lncRNA-protein interactions (e.g., WDR5 binding)

03

Biological functions

Regulation of inflammatory gene expressionPriming of chemokine gene promoters (CXCL cluster)Recruitment of histone-modifying enzyme complexes (WDR5–MLL1)Organization of 3D chromatin and TADsEpigenetic marking (H3K4me3)Modulation of innate immunity and trained immunity
04

Disease associations

InflammationImmune response regulationInfection (innate/adaptive immunity)
05

Safety considerations

Therapeutic targeting of lncRNAs has potential off-target risks due to complex chromatin architecture and species specificityLack of evolutionary conservation may limit translational modelsPotential effects on broad immune gene networks and risk of impaired immune responses
06

Biomarkers

Expression of UMLILO itself as a marker for inflammatory gene primingActivation state of CXCL chemokine genes (e.g., CXCL8, CXCL1, CXCL2, CXCL3)H3K4me3 methylation status at chemokine promoters

Beyond the preview

Go deeper on Upstream master long non-coding RNA of the inflammatory chemokine locus (UMLILO).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Upstream master long non-coding RNA of the inflammatory chemokine locus (UMLILO).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call